PAVmed Inc. (PAVM) stock
PAVMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$1.32−0.19 (-12.58%)
Close on Nov 18, 2026Market cap $10.55MP/E –Yield –
PAVmed revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
PAVmed's revenue for the twelve months ending Jun 30, 2026 was $112.00K, down 89.0% year over year. For fiscal 2025 it was $71.00K, down 97.6% from the year before. The highest annual figure on record is $3.00M in fiscal 2024.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $71.00K | -97.6% |
| FY2024 | Dec 31, 2024 | $3.00M | +22.1% |
| FY2023 | Dec 31, 2023 | $2.45M | +550.4% |
| FY2022 | Dec 31, 2022 | $377.00K | -24.6% |
| FY2021 | Dec 31, 2021 | $500.00K | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $33.00K | +450.0% |
| Q1 FY2026 | Mar 31, 2026 | $22.00K | +175.0% |
| Q4 FY2025 | Dec 31, 2025 | $52.00K | +420.0% |
| Q3 FY2025 | Sep 30, 2025 | $5.00K | -99.5% |
| Q2 FY2025 | Jun 30, 2025 | $6.00K | -99.4% |
| Q1 FY2025 | Mar 31, 2025 | $8.00K | -99.2% |
| Q4 FY2024 | Dec 31, 2024 | $10.00K | -99.0% |
| Q3 FY2024 | Sep 30, 2024 | $996.00K | +25.9% |
| Q2 FY2024 | Jun 30, 2024 | $979.00K | +489.8% |
| Q1 FY2024 | Mar 31, 2024 | $1.01M | +126.5% |
| Q4 FY2023 | Dec 31, 2023 | $1.05M | +836.6% |
| Q3 FY2023 | Sep 30, 2023 | $791.00K | +940.8% |
| Q2 FY2023 | Jun 30, 2023 | $166.00K | – |
| Q1 FY2023 | Mar 31, 2023 | $446.00K | +136.0% |
| Q4 FY2022 | Dec 31, 2022 | $112.00K | -62.7% |
| Q3 FY2022 | Sep 30, 2022 | $76.00K | -62.0% |
| Q2 FY2022 | Jun 30, 2022 | $0 | – |
| Q1 FY2022 | Mar 31, 2022 | $189.00K | – |
| Q4 FY2021 | Dec 31, 2021 | $300.00K | – |
| Q3 FY2021 | Sep 30, 2021 | $200.00K | – |
See a number that looks wrong?